Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
The original version of this Article omitted the following from the Acknowledgements: ‘This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program under Award No. W81XWH-15-1-0692. Opinions, interpretations, conclusions a...
Guardado en:
Autores principales: | Raffaella Rossin, Ron M. Versteegen, Jeremy Wu, Alisher Khasanov, Hans J. Wessels, Erik J. Steenbergen, Wolter ten Hoeve, Henk M. Janssen, Arthur H. A. M. van Onzen, Peter J. Hudson, Marc S. Robillard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fea92d6bbdb8481183adf2d4a9442582 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
por: Raffaella Rossin, et al.
Publicado: (2018) -
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
por: Wenyan Fu, et al.
Publicado: (2019) -
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
por: Yinghua Zhao, et al.
Publicado: (2016) -
Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
por: Rodrigo Vazquez-Lombardi, et al.
Publicado: (2017) -
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
por: Christopher S. Lunde, et al.
Publicado: (2019)